Published in Cell Stress Chaperones on September 06, 2010
Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study. Lipids Health Dis (2016) 1.44
Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery. Mediators Inflamm (2012) 1.16
The autoimmune concept of atherosclerosis. Curr Opin Lipidol (2011) 1.04
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases as novel stress markers in children and young adults on chronic dialysis. Cell Stress Chaperones (2010) 0.91
Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases. World J Nephrol (2013) 0.91
Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS. Blood (2015) 0.90
Markers of increased cardiovascular risk in patients with chronic kidney disease. Lipids Health Dis (2014) 0.84
Protective effect of exogenous matrix metalloproteinase-9 on chronic renal failure. Exp Ther Med (2013) 0.82
Hemodialysis removes uremic toxins that alter the biological actions of endothelial cells. PLoS One (2012) 0.80
Heat shock protein 90 inhibition by 17-Dimethylaminoethylamino-17-demethoxygeldanamycin protects blood-brain barrier integrity in cerebral ischemic stroke. Am J Transl Res (2015) 0.78
Matrix metalloproteinase (MMP-2, -9) and tissue inhibitor (TIMP-1, -2) activity in tear samples of pediatric type 1 diabetic patients: MMPs in tear samples from type 1 diabetes. Graefes Arch Clin Exp Ophthalmol (2012) 0.78
Decreases in plasma MMP-2/TIMP-2 and MMP-9/TIMP-1 ratios in uremic patients during hemodialysis. Clin Exp Nephrol (2015) 0.77
Matrix Metalloproteinases and Subclinical Atherosclerosis in Chronic Kidney Disease: A Systematic Review. Int J Nephrol (2016) 0.75
Matrix Metalloproteinase (MMP)-9 Levels in Children on Hemodialysis: Association with MMP-9 C(-1562)T Gene Polymorphism and Vitamin D Levels. Int J Biomed Sci (2016) 0.75
The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics (2004) 31.85
Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol (2004) 2.59
Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc Natl Acad Sci U S A (2005) 2.19
Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol (2008) 2.17
Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest (1999) 2.13
Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation (2004) 1.91
Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol (2006) 1.79
Identification of human heat shock protein 60 (Hsp60) and anti-Hsp60 antibodies in the peripheral circulation of normal individuals. Cell Stress Chaperones (1999) 1.62
Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury. FASEB J (2006) 1.59
Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis. Arterioscler Thromb Vasc Biol (2005) 1.56
Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest (1995) 1.45
Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis. Circulation (2006) 1.36
Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice. Arterioscler Thromb Vasc Biol (2006) 1.35
TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation. Circ Res (2010) 1.32
Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis. Cardiovasc Res (2010) 1.23
Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler Thromb Vasc Biol (2003) 1.22
The autoimmune origin of atherosclerosis. Atherosclerosis (2008) 1.17
Plasma levels of Hsp70 and anti-Hsp70 antibody predict risk of acute coronary syndrome. Cell Stress Chaperones (2010) 1.17
Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats. Atherosclerosis (2007) 1.15
Autoimmunity in atherosclerosis: a protective response losing control? J Intern Med (2008) 1.12
Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease. Circulation (2009) 1.12
Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy. J Nephrol (2007) 1.07
Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension. Free Radic Biol Med (2009) 1.05
Extracellular heat shock protein 70 (HSPA1A) and classical vascular risk factors in a general population. Cell Stress Chaperones (2010) 1.04
Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women. Atherosclerosis (2009) 1.04
Relationships between circulating matrix metalloproteinase-2 and -9 and renal function in patients with chronic kidney disease. Clin Chim Acta (2005) 1.03
Antibodies against heat shock proteins in environmental stresses and diseases: friend or foe? Cell Stress Chaperones (2006) 1.01
Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients. Atherosclerosis (2006) 0.98
Ischemia injury alters endothelial cell properties of kidney cortex: stimulation of MMP-9. Exp Cell Res (2005) 0.98
Matrix metalloproteinases and their inhibitions in experimental renal scarring. Exp Nephrol (2002) 0.93
Oxidative stress activates MMP-2 in cultured human coronary smooth muscle cells. Fundam Clin Pharmacol (2005) 0.92
Heat-shock protein 90: a novel autoantigen in human carotid atherosclerosis. Atherosclerosis (2009) 0.91
Heat shock proteins and autoimmunity in patients with carotid atherosclerosis. Ann N Y Acad Sci (2007) 0.89
Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease? Kidney Blood Press Res (2009) 0.89
Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study. Eur J Cardiovasc Prev Rehabil (2009) 0.87
Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritis. J Am Soc Nephrol (2003) 0.86
Cardiovascular disease in children with chronic kidney disease. Adv Chronic Kidney Dis (2005) 0.86
Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndrome. Clin Sci (Lond) (2009) 0.85
Searching for biomarker patterns characterizing carotid atherosclerotic burden in patients with reduced renal function. Nephrol Dial Transplant (2007) 0.85
Serum matrix metalloproteinases MMP-2 and MMP-3 levels in dialysis patients vary independently of CRP and IL-6 levels. Nephron (2002) 0.84
Elevated serum levels of proinflammatory cytokines and biomarkers of matrix remodeling in never-treated patients with familial hypercholesterolemia. Clin Chim Acta (2005) 0.84
The heat shock protein profile in children with chronic kidney disease. Perit Dial Int (2010) 0.83
MMP-7 as a potential marker of cardiovascular complications in patients with chronic kidney disease (CKD). Basic Clin Pharmacol Toxicol (2012) 1.99
Plasma ghrelin levels in children with chronic renal failure on peritoneal dialysis. Perit Dial Int (2006) 1.52
Serum VCAM-1, ICAM-1, and L-selectin levels in children and young adults with chronic renal failure. Pediatr Nephrol (2004) 1.44
Polish 2010 growth references for school-aged children and adolescents. Eur J Pediatr (2010) 1.40
Effect of kidney transplantation on heart conduction disturbances in children treated with chronic hemodialysis--a pilot study. Pediatr Transplant (2011) 1.18
Heart ventricular activation in VAT difference maps from children with chronic kidney disease. Pediatr Nephrol (2011) 1.17
Matrix metalloproteinases and soluble Fas/FasL system as novel regulators of apoptosis in children and young adults on chronic dialysis. Apoptosis (2011) 0.98
Perception of health-related quality of life in children with chronic kidney disease by the patients and their caregivers: multicentre national study results. Qual Life Res (2013) 0.94
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases as novel stress markers in children and young adults on chronic dialysis. Cell Stress Chaperones (2010) 0.91
Hypertension in dialysed children: the prevalence and therapeutic approach in Poland--a nationwide survey. Nephrol Dial Transplant (2005) 0.91
New markers of apoptosis in children on chronic dialysis. Apoptosis (2013) 0.90
Interleukin-18 in urine and serum of children with idiopathic nephrotic syndrome. Kidney Blood Press Res (2008) 0.84
Usefulness of body surface potential mapping for early identification of the intraventricular conduction disorders in young patients with chronic kidney disease. J Electrocardiol (2009) 0.83
Heat shock proteins in chronic kidney disease. Pediatr Nephrol (2010) 0.83
The heat shock protein profile in children with chronic kidney disease. Perit Dial Int (2010) 0.83
The impact of dialysis modality on serum heat shock proteins in children and young adults with chronic kidney disease. Kidney Blood Press Res (2009) 0.83
Lymphoepithelioma-like thymic carcinoma in a 16-year-old boy with nephrotic syndrome--a case report. Pediatr Nephrol (2008) 0.82
Extracellular Hsp27 in patients with chronic kidney disease. Kidney Int (2013) 0.81
Heat shock proteins in children and young adults on chronic hemodialysis. Pediatr Nephrol (2009) 0.80
Spontaneous rupture of kidney due to posterior urethral valve-diagnostic difficulties. Iran J Pediatr (2013) 0.80
The sFas/sFasL ratio as a novel marker of inflammation in children with chronic kidney disease. Clin Chim Acta (2012) 0.80
Hsp27 as a marker of cell damage in children on chronic dialysis. Cell Stress Chaperones (2012) 0.80
Is carnosinase 1 gene (CNDP1) polymorphism associated with chronic kidney disease progression in children and young adults? results of a family-based study. Arch Med Res (2010) 0.80
[Osteopontin, platelet-derived growth factor and bone morphogenetic protein-7 in children with chronic kidney disease on renal replacement therapy--preliminary results]. Pol Merkur Lekarski (2009) 0.80
Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy. Pediatr Nephrol (2014) 0.79
Soluble adhesion molecules in children and young adults on chronic hemodialysis. Pediatr Nephrol (2004) 0.79
Elastase, α1-proteinase inhibitor, and interleukin-8 in pre-dialyzed and hemodialyzed patients with chronic kidney disease. Pediatr Int (2010) 0.79
[Usefulness of osteocalcin and CrossLaps as markers of bone turnover in children with chronic renal failure]. Pol Merkur Lekarski (2002) 0.79
Psychosocial aspects of children and families of children treated with automated peritoneal dialysis. Pediatr Nephrol (2013) 0.78
Ca2+-Mg2+-dependent ATP-ase activity and calcium homeostasis in children with chronic kidney disease. Pediatr Nephrol (2006) 0.77
Skin autofluorescence as a marker of cardiovascular risk in children with chronic kidney disease. Pediatr Nephrol (2012) 0.77
Pulse volume changes recorded by air plethysmography during single hemodialysis sessions. Blood Purif (2008) 0.77
[The influence of haemodialysis on hearing organ of children with chronic renal failure]. Otolaryngol Pol (2002) 0.77
Analysis of collagen IV and fibronectin in blood and urine in evaluation of nephrotic fibrosis in children with chronic glomerulonephritis. Med Sci Monit (2002) 0.77
[Chronic peritoneal dialysis in infants--preliminary results of the multicenter survey]. Przegl Lek (2006) 0.76
Zeta chain expression in T and NK cells in peripheral blood of children with nephrotic syndrome. Pediatr Nephrol (2009) 0.76
[Osteopontin (OPN), PDGF-BB (platelet-derived growth factor) and BMP-7 (bone morphogenetic protein) as markers of atherogenesis in children with chronic kidney disease (CKD) treated conservatively--preliminary results]. Pol Merkur Lekarski (2008) 0.76
[Ormond's disease in 17-year-old girl: a case study]. Pol Merkur Lekarski (2008) 0.76
Pleiotropic functions of TIMP-1 in patients with chronic kidney disease. Cell Mol Life Sci (2014) 0.76
[Interleukin-17 concentration in serum and urine of children with idiopathic nephrotic syndrome]. Przegl Lek (2006) 0.75
Elastase, α1-proteinase inhibitor, and interleukin-8 in children and young adults with end-stage kidney disease undergoing continuous ambulatory peritoneal dialysis. Arch Immunol Ther Exp (Warsz) (2013) 0.75
Cardiovascular peculiarities in patients with chronic kidney disease. Basic Clin Pharmacol Toxicol (2012) 0.75
Ca(2+)-Mg (2+)-dependent ATP-ase activity in hemodialyzed children. Effect of a hemodialysis session. Pediatr Nephrol (2010) 0.75
Augmentation index as a vascular marker independent of inflammation. Nephrol Dial Transplant (2011) 0.75
Skin autofluorescence as a novel marker of vascular damage in children and adolescents with chronic kidney disease. Pediatr Nephrol (2014) 0.75
Anxiety in children and adolescents with chronic kidney disease--multicenter national study results. Kidney Blood Press Res (2013) 0.75
[Arterial hypertension in children and adolescents living in Kluczbork City]. Wiad Lek (2005) 0.75
Procollagen I carboxyterminal propeptide (PICP) as a bone formation marker and carboxyterminal telopeptide of type I collagen (ICTP) as a bone degradation marker in children with chronic renal failure under conservative therapy. Med Sci Monit (2003) 0.75
[Vaccinations in children with idiopathic nephrotic syndrome]. Med Wieku Rozwoj (2011) 0.75
The impact of dialysis modality on novel markers of stress reaction, matrix remodeling and endothelial damage in children on chronic dialysis. Blood Purif (2014) 0.75
[Expression of zeta (zeta) chain in peripheral blood T lymphocytes and NK cells of children with idiopathic nephrotic syndrome (INS)--preliminary results]. Przegl Lek (2006) 0.75
[The influence of hemodialysis on heart's intraventricular conduction system--pilot study]. Pol Merkur Lekarski (2009) 0.75
Effects of hemodialysis on ventricular activation time in children with end-stage renal disease. Hemodial Int (2014) 0.75
Erratum to: Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy. Pediatr Nephrol (2015) 0.75
[Structure and function of the glomerular filtration barrier]. Pol Merkur Lekarski (2005) 0.75
[Prune-belly syndrome and therapeutic problems]. Pol Merkur Lekarski (2008) 0.75
[Serum adiponectin and resistin level in children with idiopathic nephrotic syndrome]. Pol Merkur Lekarski (2009) 0.75
Crossed renal ectopia: can it be a diagnostic problem? Postepy Hig Med Dosw (Online) (2012) 0.75
[CIP and CAP fragments of parathormone and selected parameters of calcium-phosphate balance in patients with chronic kidney disease treated with repeated haemodialysis]. Pediatr Endocrinol Diabetes Metab (2010) 0.75
[Calpain-calpastatin system in erythrocytes of children with chronic renal failure]. Przegl Lek (2006) 0.75
[Antibodies against heat shock proteins (HSP) in children with chronic renal failure (CRF)--preliminary results]. Przegl Lek (2006) 0.75
[Assessment of function of the only kidney in children after nephrectomy due to Wilms tumor]. Pol Merkur Lekarski (2003) 0.75
[Evaluation of renal function in children undergoing surgery under general anaesthesia]. Pol Merkur Lekarski (2002) 0.75
[Blood and urine endothelin and nitric oxide levels in predialysis children with chronic renal failure]. Przegl Lek (2006) 0.75
Fungal urinary tract infection complicated by acute kidney injury in an infant with intestino-vesical fistula. Postepy Hig Med Dosw (Online) (2013) 0.75
[Serum apolipoproteins A1, B and Apo A1/Apo B index in children with advanced chronic renal failure and on dialysis]. Pol Merkur Lekarski (2003) 0.75
[Prognostic factors in children with lupus nephritis]. Wiad Lek (2005) 0.75
[Apoptosis in patients with chronic renal failure (CRF)]. Przegl Lek (2006) 0.75
Urine survivin, E-cadherin and matrix metalloproteinases as novel biomarkers in children with chronic kidney disease. Biomarkers (2015) 0.75
[Adhesion molecules in patients with chronic renal failure treated with haemodialysis]. Pol Merkur Lekarski (2002) 0.75
Subclinical hypothyroidism as a rare cofactor in chronic kidney disease (CKD) - related anemia. J Pediatr Endocrinol Metab (2015) 0.75